WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Fine Science Tools - Extraordinary Craftsmanship
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baizer, L.
Right arrow Articles by Weiner, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baizer, L.
Right arrow Articles by Weiner, N.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 5, 1176-1179, Copyright © 1985 by Society for Neuroscience


ARTICLE

Nerve growth factor treatment enhances nicotine-stimulated dopamine release and increases in cyclic adenosine 3':5'-monophosphate levels in PC12 cell cultures

L Baizer and N Weiner

In order to examine the relationship between cyclic AMP (cAMP) levels and evoked neurotransmitter release, experiments have been performed with cultures of clonal rat PC12 pheochromocytoma cells. Stimulation of the release of endogenous dopamine by nicotine in these cultures is calcium-dependent and blocked by d-tubocurarine, a specific nicotinic cholinergic antagonist. Similarly, nicotine causes increases in cAMP levels in PC12 cell cultures that are calcium-dependent and blocked by d-tubocurarine. Cultures treated for 6 days or longer with 2 X 10(-9) M nerve growth factor (NGF) release a 3- to 4-fold greater amount of dopamine than do control cultures in response to a maximal concentration of nicotine. Correspondingly, nicotine causes a 3-fold greater increase in cAMP levels in the NGF-treated cultures than in the controls. These results suggest that stimulation of the nicotinic cholinergic receptor in PC12 cells results in some manner in the activation of adenylate cyclase and further support the notion that cAMP is involved in the process of neurotransmitter release.


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. M. Avila, M. I. Davila-Garcia, V. S. Ascarrunz, Y. Xiao, and K. J. Kellar
Differential Regulation of Nicotinic Acetylcholine Receptors in PC12 Cells by Nicotine and Nerve Growth Factor
Mol. Pharmacol., October 1, 2003; 64(4): 974 - 986.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. J. Dewar, B. U. Bradford, and R. G. Thurman
Nicotine Increases Hepatic Oxygen Uptake in the Isolated Perfused Rat Liver by Inhibiting Glycolysis
J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 930 - 937.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-